𝔖 Bobbio Scriptorium

✦ LIBER ✦

Adjuvant Trastuzumab Reduces Locoregional Recurrence in Women Who Receive Breast-Conservation Therapy for Lymph Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

✍ Scribed by Register, S.; Wright, J.L.

Book ID: 123156129
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 51 KB
Volume: 23
Category: Article
ISSN: 1043-321X
DOI: 10.1016/j.breastdis.2012.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

Seven-Year Follow-Up Assessment of Cardi

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

✍ Zibelman, M.; Goldstein, L.J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB